From 2022 through 2024, U.S. businesses were forced to capitalize and amortize their domestic R&D expenses over five years instead of deducting them immediately. For R&D-intensive companies — especially software firms, manufacturers, and startups — this created enormous taxable income from phantom profits. You couldn’t deduct the salaries you paid your engineers this year; you had to spread that deduction over five years. Companies with $5M in R&D payroll suddenly owed taxes on income they never earned.
The OBBBA fixed it. New Section 174A, effective for tax years beginning after December 31, 2024, permanently restores immediate expensing for domestic R&D. But the transition isn’t automatic — you need to make specific elections and accounting method changes, some with hard deadlines. Here’s what happened, what your options are, and what you need to do before July 6, 2026.
Key Takeaways
- Section 174A permanently restores immediate expensing for domestic R&D costs, effective for tax years beginning after December 31, 2024
- For unamortized 2022-2024 R&D costs, all businesses can either deduct 100% in 2025 or split 50/50 across 2025-2026
- Small businesses (≤$31M average gross receipts) can retroactively apply Section 174A to 2022-2024 by amending returns — deadline July 6, 2026
- Foreign R&D expenses still require 15-year amortization — the OBBBA did not change this, making domestic vs. foreign cost allocation critical
What Section 174 Required (2022-2024)
Before we get into the fix, understanding what broke helps explain why the transition matters. The Tax Cuts and Jobs Act of 2017 amended Section 174 to require, beginning in 2022, that all research and experimental (R&E) expenditures be capitalized and amortized over five years for domestic research and fifteen years for foreign research. Before this change, companies had been immediately deducting R&D costs for decades.
The impact was severe. Consider a software company with $3M in annual developer payroll and zero profit. Under pre-TCJA rules, that $3M was fully deductible in the year paid, resulting in zero taxable income. Under the TCJA amortization requirement, only $600,000 was deductible in year one (1/5 of $3M), creating $2.4M in phantom taxable income — and a tax bill on income the company never earned.
Why it also hurt R&D credit claims: The amortization requirement didn’t just create phantom income — it complicated R&D credit calculations. The Section 280C coordination between the credit and the deduction became more complex, and many companies chose not to claim the R&D credit during 2022-2024 because the interaction between amortized deductions and credits was confusing or seemed unfavorable. The OBBBA’s Section 174A simplifies this interaction significantly.
What Section 174A Fixed (Effective 2025)
Permanent Legislative Change
The OBBBA, signed July 4, 2025, added new Section 174A to the Internal Revenue Code. This provision permanently restores immediate expensing for domestic R&E expenditures for tax years beginning after December 31, 2024. The key features:
Section 174A — What It Does
Immediate deduction is the default
All domestic R&E expenditures paid or incurred during the tax year are deductible in full in the year incurred. This is the default treatment — no election required.
Optional capitalization available
Taxpayers may elect to capitalize and amortize domestic R&E over not less than 60 months under Section 174A(c). This election applies to the current and subsequent years. Useful if a company expects significantly higher income in future years and wants to smooth taxable income.
Foreign R&D unchanged
Foreign R&E expenditures must still be capitalized and amortized over 15 years under Section 174. The OBBBA did not change this — creating a clear incentive to conduct research domestically.
Permanent — no sunset
Unlike many TCJA provisions, Section 174A has no expiration date. Immediate expensing is now permanent law, providing long-term planning certainty.
The Three Options for Your 2022-2024 Costs
If you capitalized domestic R&D expenses during 2022-2024 under the TCJA’s amortization requirement, you have unamortized balances sitting on your books. The OBBBA and Rev. Proc. 2025-28 give you three paths to deal with them:
A
Continue amortizing (default — no action required)
If you do nothing, the remaining unamortized domestic R&E costs from 2022-2024 continue to be amortized over the original 5-year period. This is the default position and requires no filing action. Available to all businesses.
B
Accelerate — deduct remaining balance in 2025 or split 2025-2026
Deduct the entire remaining unamortized balance in 2025 (the “flush” option), or split it 50/50 across 2025 and 2026. This is done via an accounting method change under Rev. Proc. 2025-28, attached to your 2025 return. Available to all businesses. For most companies, this is the best default choice — it captures the remaining deductions as fast as possible.
C
Retroactive election — amend 2022-2024 returns
Apply Section 174A retroactively to 2022, 2023, and 2024 by filing amended returns for all affected years. This is the most powerful option — it effectively treats your R&D costs as immediately deductible in the years they were incurred, generating potential refunds. Available only to eligible small businesses (average annual gross receipts of $31M or less). All-or-nothing rule: if you elect, you must amend all affected years. Deadline: July 6, 2026.
Check your statute of limitations now: The July 6, 2026 deadline applies only if your statute of limitations hasn’t already expired. For a calendar-year company that filed its 2022 return on April 15, 2023, the statute expired April 15, 2026 — just two days ago. If you haven’t filed your 2022 amended return yet for that year, it may already be too late for the retroactive election on that year. The 2023 and 2024 windows are still open for most companies, but they’re closing fast. Don’t wait to evaluate this.
How Section 174A Interacts with the R&D Credit
The R&D deduction (Section 174A) and the R&D credit (Section 41) are separate provisions that work together — and the coordination between them is governed by Section 280C. Here’s how they interact:
The §280C election matters more now: With Section 174A restoring immediate expensing, the reduced credit election (keeping the full deduction) is usually more favorable than it was during the amortization years. The math depends on your specific tax rate, NOL position, and state tax conformity — but the general rule is: if you can immediately deduct 100% of your R&D costs, the 21% haircut on the credit is usually worth it because the full deduction saves more in taxes than the 21% credit reduction costs. Run the numbers both ways before filing.
What You Need to Do for Your 2025 Return
Every business that incurs domestic R&D expenses must make an accounting method change for 2025 — the first tax year under Section 174A. Here’s the action plan:
2025 Tax Year Action Checklist:
| ✓ | Choose your Section 174A method. Default is immediate deduction. You may alternatively elect 60-month amortization under §174A(c). The election applies to the current and subsequent years, so choose carefully. |
| ✓ | Decide what to do with unamortized 2022-2024 balances. Continue amortizing (default), accelerate to 2025 (or split 2025-2026), or retroactively amend if you qualify as a small business. |
| ✓ | Make the §280C election on your 2025 return. Full credit with reduced deduction, or reduced credit with full deduction. This election must be made on the original timely-filed return — it’s irrevocable for the year. Model both scenarios before filing. |
| ✓ | Separate domestic vs. foreign R&D expenses. Domestic costs get immediate deduction. Foreign costs stay on 15-year amortization. If you have offshore teams, proper geographic allocation is critical — and it affects both the deduction and the credit. |
| ✓ | Evaluate whether to claim R&D credits for 2022-2024. If you skipped R&D credit claims during the amortization years because the interaction seemed unfavorable, revisit them now — especially if you’re filing amended returns under the retroactive election. Credits you didn’t claim on the original return can be included on the amended return. |
The Small Business Retroactive Election — Before It’s Too Late
This is the most time-sensitive opportunity in the entire OBBBA. If your average annual gross receipts for 2022-2024 are $31 million or less (measured under the Section 448(c) test, including controlled group aggregation under §52), you can retroactively apply Section 174A to every year since 2022.
Here’s what that means in practice: you go back to 2022, 2023, and 2024 and treat your domestic R&D costs as immediately deductible in each of those years — as if the TCJA amortization requirement never existed. The difference between what you deducted (amortized portion) and what you should have deducted (full amount) generates a refund for each year.
Who qualifies
Average annual gross receipts of $31M or less for 2022-2024 (per Section 448(c)). Includes controlled group aggregation — related entities under common control must be combined. Even if your individual entity is small, check the aggregated group total.
The catch
All-or-nothing: you must amend every affected year (2022, 2023, 2024) — you can’t pick and choose. The deadline is the earlier of July 6, 2026 or the statute of limitations for the applicable tax year. For 2022 returns filed on time, the statute may have already closed in April 2026.
From our practice: For qualifying small businesses, the retroactive election is almost always the right choice — but it requires careful execution. The amended returns must correctly recalculate the R&D deduction, adjust taxable income, recompute the R&D credit (including the Section 280C election), and flow through to any affected state returns. For pass-through entities, the changes cascade to every partner’s or shareholder’s individual return. We’ve seen companies generate six-figure refunds from the retroactive election, but the complexity demands professional preparation.
State Conformity: A Critical Wrinkle
Not every state conforms to the OBBBA’s Section 174A changes, and the nonconformity can create significant state-level complications. For California businesses specifically:
California never adopted the TCJA’s Section 174 amortization requirement — the state always allowed full R&D expensing. However, California has its own conformity analysis for the OBBBA’s changes. SB 711 updated California’s IRC conformity date to January 1, 2025, but with specific exceptions. Whether California conforms to Section 174A specifically requires a case-by-case analysis. Other states that have decoupled from the federal amortization requirement — or that conform to a pre-OBBBA version of the IRC — may require separate state-level calculations. If you operate in multiple states, each state’s conformity position must be evaluated independently.
July 6, 2026 Is Coming. Are You Ready?
If you qualify for the small business retroactive election, the deadline to amend your 2022-2024 returns is approaching fast. We’ll evaluate your eligibility, model the refund potential, and handle the amended return preparation — including R&D credit coordination.
Frequently Asked Questions
Is the immediate expensing permanent?
Yes. Section 174A has no sunset date. Unlike many TCJA provisions that expire, immediate R&D expensing is now permanent law. This provides long-term planning certainty for businesses investing in domestic research.
Do I have to file Form 3115 for the accounting method change?
For most taxpayers, Rev. Proc. 2025-28 provides automatic consent for the method change by attaching a statement to the 2025 return. This simplifies the process compared to the traditional Form 3115 filing. The method change to Section 174A is made on a cut-off basis — no Section 481(a) adjustment is required for the change itself (though the acceleration of unamortized balances is handled separately).
What about software development costs specifically?
Software development costs that constitute R&E expenditures are covered by Section 174A and eligible for immediate expensing. Software companies were hit hardest by the TCJA amortization requirement because developer salaries represent such a large percentage of total expenses. Section 174A provides the most relief to exactly these companies.
Can I claim R&D credits I didn’t claim during 2022-2024?
Potentially. If you’re filing amended returns under the small business retroactive election, you can include R&D credit claims you didn’t make on the original returns for those years. Even without the retroactive election, you can generally amend returns within the 3-year statute of limitations to claim missed credits. For 2022 returns, the statute may have already closed — act quickly on 2023 and 2024.
How does this affect QRE calculations for the R&D credit?
QREs under Section 41 are determined by their own rules — they are not directly changed by Section 174A. However, the Section 280C coordination between the credit and the deduction does change. With immediate expensing restored, the reduced credit election (§280C(c)(2)) usually becomes more favorable for most taxpayers. Your R&D credit specialist should model both options. Read our complete R&D tax credit guide for credit calculation details.
What Should You Do Next?
Section 174A is one of the most significant R&D-related tax changes in a decade. If you incur domestic R&D expenses — whether you’re a software company, a manufacturer, a food company, or a construction firm — you need to make specific elections on your 2025 return, and if you’re an eligible small business, the retroactive election window is closing.
Schedule a free consultation and we’ll evaluate your Section 174A options, model the retroactive election if you qualify, and coordinate everything with your R&D credit study and return preparation.
Learn more about the IRS four-part test →
CPAs: partner with us to navigate Section 174A for your clients →
Martin Gamez
Founder, Tax Formulations
Martin is a tax credit specialist with over 25 years of experience in federal and state R&D tax credits, cost segregation, and business tax incentives. His background includes tenure at Big Four and Top 10 accounting firms, with deep expertise in Section 174/174A transition planning and R&D credit coordination. Read full bio →
